Kos J - Search Results

1

Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma.

Smid L, Strojan P, Budihna M, Skrk J, Vrhovec I, Zargi M, Kos J. Smid L, et al. Among authors: kos j. Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S150-3. doi: 10.1007/BF02439748. Eur Arch Otorhinolaryngol. 1997. PMID: 9065652

2

Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.

Kos J, Smid A, Krasovec M, Svetic B, Lenarcic B, Vrhovec I, Skrk J, Turk V. Kos J, et al. Biol Chem Hoppe Seyler. 1995 Jul;376(7):401-5. doi: 10.1515/bchm3.1995.376.7.401. Biol Chem Hoppe Seyler. 1995. PMID: 7576236

3

Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.

Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, Rudolf Z, Zargi M, Krasovec M, Svetic B, Kopitar-Jerala N, Kos J. Budihna M, et al. Among authors: kos j. Biol Chem Hoppe Seyler. 1996 Jun;377(6):385-90. doi: 10.1515/bchm3.1996.377.6.385. Biol Chem Hoppe Seyler. 1996. PMID: 8839984 Clinical Trial.

4

Cysteine proteinases in cancer progression and their clinical relevance for prognosis.

Lah TT, Kos J. Lah TT, et al. Among authors: kos j. Biol Chem. 1998 Feb;379(2):125-30. Biol Chem. 1998. PMID: 9524063 Review.

5

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.

Kos J, Nielsen HJ, Krasovec M, Christensen IJ, Cimerman N, Stephens RW, Brünner N. Kos J, et al. Clin Cancer Res. 1998 Jun;4(6):1511-6. Clin Cancer Res. 1998. PMID: 9626470

6

Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review).

Kos J, Lah TT. Kos J, et al. Oncol Rep. 1998 Nov-Dec;5(6):1349-61. doi: 10.3892/or.5.6.1349. Oncol Rep. 1998. PMID: 9769367 Review.

7

Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.

Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, Vrhovec I. Kos J, et al. Clin Cancer Res. 1997 Oct;3(10):1815-22. Clin Cancer Res. 1997. PMID: 9815568

8

Molecular cloning and chimerisation of CDI 315B monoclonal antibody.

Kopitar-Jerala N, Bestagno M, Fan X, Novak-Despot D, Burrone O, Kos J, Skrk J, Gubensek F. Kopitar-Jerala N, et al. Among authors: kos j. Pflugers Arch. 2000;439(3 Suppl):R79-80. Pflugers Arch. 2000. PMID: 10653149

9

Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.

Lah TT, Cercek M, Blejec A, Kos J, Gorodetsky E, Somers R, Daskal I. Lah TT, et al. Among authors: kos j. Clin Cancer Res. 2000 Feb;6(2):578-84. Clin Cancer Res. 2000. PMID: 10690542

10

Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.

Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, Skrk J. Strojan P, et al. Among authors: kos j. Clin Cancer Res. 2000 Mar;6(3):1052-62. Clin Cancer Res. 2000. PMID: 10741734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters